Conference abstractPublished 23 Nov 2012
Process Analytical Technology (PAT): An ideal or an achievable option for quality assurance?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Process Analytical Technology (PAT) began with an initiative of the Food and Drug Administration (FDA) in USA, during its Science Board Meetings of 11/01 and 4/02. Science Board supported for FDA?s proposal to facilitate innovation in the field of pharmaceutical manufacturing. This decision was materialized by a guideline ?PAT ? A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance? released in September 2004. The aim of this guideline is to encourage industrials to innovate ?voluntarily? in manufacturing and to give them a guarantee of regulatory approval. PAT refers commonly to a system for designing, analyzing, and controlling manufacturing by timely measurements of critical quality and performance attributes of raw and in-process materials. It suggests the possibility of real time release of final products batches. In this work, we focus on the PAT tools for design, data acquisition and analysis, and on the feasibility of implementing these tools in a pharmaceutical plant to improve the level of quality assurance.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Yacine Sellam”
